Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Update: D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma [Phase 3]
Phase 3 trial investigating D2 resection with HIPEC in locally advanced gastric carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) [Phase 1, Phase 2]
Phase 1/2 study evaluating multiple immunotherapy-based combinations in locally advanced unresectable or metastatic gastric/GEJ cancer and e…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating trastuzumab deruxtecan in combination with nivolumab, capecitabine, and oxaliplatin for HER2-low gastric and ga…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical study of regorafenib and nivolumab plus chemotherapy for gastric and gastroesophageal junction adenocarcinoma (an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer [Phase 4]
Phase 4 trial evaluating genetic analysis-guided dosing of irinotecan within mFOLFIRINOX for locally advanced gastroesophageal and stomach c…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Magnetic Sentinel Lymph Node Mapping in Gastric Cancer [Phase 1]
Phase 1 clinical trial evaluating magnetic sentinel lymph node mapping for staging in gastric adenocarcinoma; the study is not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers [NA]
A completed clinical trial study examined determinants of patient delay in seeking medical consultation for esophageal cancer and gastric ad…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer [Phase 3]
A Phase 3 trial comparing surgical resection plus chemotherapy versus chemotherapy alone for oligometastatic stage IV gastric cancer has bee…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy [Phase 3]
The PREACT Phase 3 trial comparing chemoradiotherapy versus chemotherapy followed by D2 gastrectomy and adjuvant chemotherapy for locally ad…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma
Completed clinical trial update reporting biomarker analysis for the tislelizumab-chemotherapy combination as perioperative treatment for ga…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors [Phase 1]
A Phase I trial of JS004, a recombinant humanized anti-BTLA monoclonal antibody, in combination with toripalimab for advanced solid tumors h…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab combined with XELOX as neoadjuvant therapy for locally advanced gastric or gastroesophageal junction a…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma [Phase 3]
A Phase 3 trial evaluating AK104 as first-line therapy for locally advanced unresectable or metastatic gastric adenocarcinoma and gastroesop…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 2]
Phase 2 study of DKN-01 in combination with tislelizumab, with or without chemotherapy, in gastric and gastroesophageal cancers was terminat…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors [Phase 1]
Phase 1a/1b study of TPST-1495 as monotherapy and in combination with pembrolizumab has completed status, spanning multiple solid tumors inc…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer [Phase 2]
A Phase 2 clinical trial update evaluating SHR-8068 in combination with Adebrelimab and platinum-based chemotherapy for advanced gastric ade…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab [Phase 1]
Phase 1 study of DKN-01 with paclitaxel or pembrolizumab in esophageal and gastroesophageal cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer [Phase 2]
Phase 2 trial evaluating IMAB362 (zolbetuximab) in combination with the EOX chemotherapy regimen for CLDN18.2-positive gastric, gastroesopha…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) [Phase 2]
Phase 2 study evaluating IMU-131 (HER-Vaxx) with chemotherapy or pembrolizumab in metastatic HER2-overexpressing gastric cancer; the trial w…